Clinical Trials Logo
  1. Home
  2. PsA
  3. NCT01749618

Closing the Gap in Care in Seronegative Inflammatory Arthritis — Metrix II  

PsA Clinical Trial

Official title:
Closing the Gap in Care in Seronegative Inflammatory Arthritis: From Identification to Implementation of Treating to Target: A Randomized Trial of Feedback, Education, and Behavioural Change

Clinical Trial Summary

Rheumatologists treating patients with seronegative arthritis will be randomized to treat their patients to a target or to treat their patients under their usual standard of care. All physicians will perform an initial chart audit. Following the initial chart audit, all physicians in the treat-to-target group will receive accredited educational training. Six months after the initial chart audit, all physicians will perform a repeat audit to see if patients are assessed more systematically and treated to a target of low disease state.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01749618
Study type Interventional
Source Pope Research Corporation
Contact
Status Completed
Phase N/A
Start date November 2012
Completion date November 2016
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05629494 - Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test Phase 4
Recruiting NCT04081636 - Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications N/A
Terminated NCT02455466 - Altered PSA Test Due to Possible Suspected Heterophilic Antibodies N/A
Completed NCT02934620 - Promoting CSD500 Use Among Women in Established Relationships N/A
Recruiting NCT04240327 - Marker Driven Selection of Patients for Prostate Biopsy and Management
Recruiting NCT04319783 - Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA Phase 2
Recruiting NCT03428087 - Prostate Impendance Test Project N/A
Recruiting NCT04251546 - Prediction Model fo Screening and Diagnosis of Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined With TPV
Recruiting NCT03891732 - MRI Prostate for Chinese Men Being Screened for Prostate Cancer
Recruiting NCT03784924 - EDRN Prostate MRI Biomarker Study
Terminated NCT01681433 - OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone Phase 2
Active, not recruiting NCT04782713 - Smart Prostate Specific Antigen (PSA) Screening Study N/A
Active, not recruiting NCT05732441 - Therapeutic Study of Prostatitis With Elevated PSA N/A
Recruiting NCT04393376 - PSA Glycomics Assay for Early Detection of Prostate Cancer N/A
Not yet recruiting NCT05306314 - Retrospective Chart Review of Treataprost Added to Antibiotic Treatment in Patients With Chronic Prostatitis